Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis
Authors:
- 28 September 2023
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 395, 131401
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Myocarditis following mRNA Covid-19 vaccination: A pooled analysisVaccine, 2022
- Myocarditis after RNA-based vaccines for coronavirus.International Journal of Cardiology, 2022
- Incidence of Myopericarditis and Myocardial Injury in Coronavirus Disease 2019 Vaccinated SubjectsThe American Journal of Cardiology, 2021
- COVID-19 Vaccine and MyocarditisThe American Journal of Cardiology, 2021
- Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Pathological Evidence for SARS-CoV-2 as a Cause of MyocarditisJACC, 2021
- COVID-19 myocarditis and long-term heart failure sequelaeCurrent Opinion in Cardiology, 2020
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsBMJ, 2016
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011